New study suggests J&J recipients should get booster shot to protect against Delta variant

Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years

By Rafi Schwartz, The Week US Published 31 January 25

Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions

By Peter Weber, The Week US Published 24 January 25

The Explainer Respiratory illness is common in winter

By Devika Rao, The Week US Published 8 January 25

In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA

By David Faris Published 20 December 24

Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized

By Rafi Schwartz, The Week US Published 19 December 24

Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people

By Peter Weber, The Week US Published 6 December 24

Speed Read The findings were based on the diets of about 192,000 US adults over 34 years

By Peter Weber, The Week US Published 5 December 24

Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election

By Peter Weber, The Week US Published 1 November 24